drugset / Trial / NCT00586287

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

NCT00586287

Phase 4 Completed 302 enrolled Cantonal Hospital of St. Gallen
RandomizedParallel-groupOpen-labelTreatment

Summary

Oral anticoagulation is often initiated in hospitalized patients. Although the therapeutic range of phenprocoumon is narrow, the individual drug demands unfortunately vary greatly between persons. Our group recently developed two dosing algorithms for the initiation of anticoagulation based on clinical predictors such as age, gender, body weight and laboratory values. The aim of the proposed study is to prospectively evaluate the efficacy and safety of these two algorithms in medical and orthopedic inpatients, as well as in a group of outpatients and possibly in a geriatric collective.

Timeline

Start
2007-01
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phenprocoumon Small molecule